When is ORGO's latest earnings report released?
The most recent financial report for Organogenesis holdings inc. (ORGO) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ORGO's short-term business performance and financial health. For the latest updates on ORGO's earnings releases, visit this page regularly.
Where does ORGO fall in the P/E River chart?
According to historical valuation range analysis, Organogenesis holdings inc. (ORGO)'s current price-to-earnings (P/E) ratio is 23.77, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of ORGO?
According to the latest financial report, Organogenesis holdings inc. (ORGO) reported an Operating Profit of 63.29M with an Operating Margin of 28.05% this period, representing a growth of 520.97% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is ORGO's revenue growth?
In the latest financial report, Organogenesis holdings inc. (ORGO) announced revenue of 225.61M, with a Year-Over-Year growth rate of 78.13%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does ORGO have?
As of the end of the reporting period, Organogenesis holdings inc. (ORGO) had total debt of 82.14M, with a debt ratio of 0.14. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does ORGO have?
At the end of the period, Organogenesis holdings inc. (ORGO) held Total Cash and Cash Equivalents of 94.33M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does ORGO go with three margins increasing?
In the latest report, Organogenesis holdings inc. (ORGO) achieved the “three margins increasing” benchmark, with a gross margin of 77.9%%, operating margin of 28.05%%, and net margin of 15.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ORGO's profit trajectory and future growth potential.
Is ORGO's EPS continuing to grow?
According to the past four quarterly reports, Organogenesis holdings inc. (ORGO)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.28. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of ORGO?
Organogenesis holdings inc. (ORGO)'s Free Cash Flow (FCF) for the period is 34.77M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 358.92% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of ORGO?
The latest valuation data shows Organogenesis holdings inc. (ORGO) has a Price-To-Earnings (PE) ratio of 23.77 and a Price/Earnings-To-Growth (PEG) ratio of 0.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
